
Lexeo Therapeutics, Inc. Common Stock
LXEOHealthcare|Biotechnology|US
$2.89
-0.01 (-0.52%)
DCF Value
$0.95
Tangible Book / Share
$2.75
Cash / Share
$2.47
Ownership Breakdown
62.4%
Float
82.1M
Shares Outstanding
51.2M
Float Shares
Major Holders (40)
Combined: 270.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Balyasny Asset Management Holdings LP | HC, PN | 9.99% | 7,844,311 | Aug 14, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 9.99% | 7,844,311 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 9.99% | 7,844,311 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 9.99% | 7,844,311 | Aug 14, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 9.99% | 7,844,311 | Aug 14, 2026 | 13D/G |
| Janus Henderson Group PLC | IA, HC | 9.99% | 7,291,434 | Dec 8, 2025 | 13D/G |
| Michael Cho | HC, IN | 8.40% | 6,674,913 | Aug 13, 2026 | 13D/G |
| Affinity Asset Advisors, LLC | IA, OO | 8.40% | 6,674,913 | Aug 13, 2026 | 13D/G |
| Affinity Healthcare Fund, LP | Partnership | 7.75% | 4,252,005 | Jun 4, 2025 | 13D/G |
| Aaron Cowen | HC, IN | 7.70% | 5,674,778 | Apr 13, 2026 | 13D/G |
| Suvretta Capital Management, LLC | IA, OO | 7.70% | 5,674,778 | Apr 13, 2026 | 13D/G |
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 7.60% | 4,076,465 | Nov 14, 2025 | 13D/G |
| Vestal Point Capital, LP | IA, PN | 7.50% | 4,117,302 | Nov 14, 2025 | 13D/G |
| Ryan Wilder | HC, IN | 7.50% | 4,117,302 | Nov 14, 2025 | 13D/G |
| Kenneth Griffin | HC, IN | 7.40% | 5,498,219 | Feb 17, 2026 | 13D/G |
| Citadel GP LLC | HC, OO | 7.20% | 5,405,269 | Feb 17, 2026 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 7.20% | 5,405,269 | Feb 17, 2026 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 7.20% | 5,405,269 | Feb 17, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 6.90% | 5,000,000 | Oct 27, 2025 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 6.90% | 5,000,000 | Oct 27, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 6.90% | 5,000,000 | Oct 27, 2025 | 13D/G |
| Peter Kolchinsky | HC, IN | 6.90% | 5,000,000 | Oct 27, 2025 | 13D/G |
| BlackRock, Inc. | Holding company | 6.70% | 4,885,814 | Jan 21, 2026 | 13D/G |
| Mizuho Financial Group, Inc. | Non-US institution | 6.60% | 2,203,631 | May 13, 2025 | 13D/G |
| Averill Master Fund, Ltd. | Corporation | 6.50% | 4,827,730 | Apr 13, 2026 | 13D/G |
| Finny Kuruvilla, M.D. Ph. D. | HC, IN | 5.61% | 1,855,986 | Nov 14, 2024 | 13D/G |
| Jpmorgan Chase & Co. | Holding company | 5.50% | 4,573,701 | Oct 13, 2026 | 13D/G |
| State Street Corporation | Holding company | 5.50% | 4,354,775 | Aug 7, 2026 | 13D/G |
| Senai Asefaw, M.D. | Individual | 5.30% | 4,175,382 | Aug 14, 2026 | 13D/G |
| Paradigm BioCapital Advisors GP LLC | Other | 5.30% | 4,175,382 | Aug 14, 2026 | 13D/G |
| Paradigm BioCapital Advisors LP | Partnership | 5.30% | 4,175,382 | Aug 14, 2026 | 13D/G |
| FHMLSP, L.P. | Partnership | 5.10% | 3,698,271 | Feb 13, 2026 | 13D/G |
| FHMLSP, L.L.C. | Other | 5.10% | 3,698,271 | Feb 13, 2026 | 13D/G |
| Frazier Life Sciences Public Fund, L.P. | Partnership | 5.10% | 3,698,271 | Feb 13, 2026 | 13D/G |
| Paradigm BioCapital International Fund Ltd. | Corporation | 4.70% | 3,662,102 | Aug 14, 2026 | 13D/G |
| OrbiMed Advisors LLC | Investment adviser | 4.10% | 3,203,050 | Aug 14, 2026 | 13D/G |
| Longitude Capital Partners IV, LLC | Other | 3.80% | 2,765,381 | Nov 14, 2025 | 13D/G |
| Longitude Venture Partners IV, L.P. | Partnership | 3.80% | 2,765,381 | Nov 14, 2025 | 13D/G |
| Patrick G. Enright | Individual | 3.80% | 2,765,381 | Nov 14, 2025 | 13D/G |
| Juliet Tammenoms Bakker | Individual | 3.80% | 2,765,381 | Nov 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,270,073 acquired · 168,601 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Tamayo Louis Edward | Chief Financial Officer | Sep 24, 2026 | AWARD | 54,750 | $3.39 | $185.6K | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Sep 14, 2026 | AWARD | 2,714 | $3.58 | $9.7K | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Sep 24, 2026 | AWARD | 54,750 | $3.39 | $185.6K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Sep 14, 2026 | AWARD | 2,110 | $2.64 | $5.6K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Sep 24, 2026 | AWARD | 54,750 | $3.39 | $185.6K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Sep 14, 2026 | AWARD | 2,306 | $2.64 | $6.1K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Sep 24, 2026 | AWARD | 145,500 | $3.39 | $493.2K | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Aug 18, 2026 | SELL | 4,117 | $4.91 | $20.2K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Aug 18, 2026 | SELL | 3,345 | $4.95 | $16.6K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Aug 18, 2026 | SELL | 1,304 | $4.96 | $6.5K | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Jun 29, 2026 | AWARD | 12,000 | — | — | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Jul 1, 2026 | SELL | 4,641 | $4.49 | $20.8K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Jun 29, 2026 | AWARD | 12,060 | — | — | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Jul 1, 2026 | SELL | 4,666 | $4.48 | $20.9K | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Jun 29, 2026 | AWARD | 55,000 | — | — | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Jul 1, 2026 | SELL | 22,306 | $4.42 | $98.6K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Jun 29, 2026 | AWARD | 67,000 | — | — | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Jul 1, 2026 | SELL | 25,947 | $4.48 | $116.2K | Form 4 |
| Altschuler Steven | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| Agger Mette Kirstine | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| COOPERSTONE BRENDA | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| DIAZ REINALDO M | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| Tanguler Tolga | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| Van Hauwermeiren Timothy | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| CHOLMONDELEY PAULA H | director | Jun 25, 2026 | AWARD | 35,000 | $4.70 | $164.5K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | May 18, 2026 | SELL | 1,302 | $5.07 | $6.6K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | May 18, 2026 | SELL | 3,342 | $5.06 | $16.9K | Form 4 |
| Sepp-Lorenzino Laura | director | Apr 28, 2026 | AWARD | 50,000 | $5.81 | $290.5K | Form 4 |
| Sepp-Lorenzino Laura | Apr 28, 2026 | OTHER | 0 | — | — | Form 4 | |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Apr 6, 2026 | SELL | 55,000 | $5.69 | $313.1K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Mar 13, 2026 | AWARD | 2,623 | $2.64 | $6.9K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Mar 13, 2026 | AWARD | 5,930 | $2.64 | $15.7K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Feb 18, 2026 | SELL | 3,016 | $6.40 | $19.3K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Feb 18, 2026 | SELL | 10,173 | $6.38 | $64.9K | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Nov 18, 2025 | SELL | 721 | $9.27 | $6.7K | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Feb 13, 2026 | AWARD | 297,000 | $6.31 | $1.9M | Form 4 |
| Bhalla Narinder Pal | Chief Medical Officer | Feb 13, 2026 | AWARD | 49,500 | — | — | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Feb 4, 2026 | AWARD | 646,665 | $7.27 | $4.7M | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Feb 4, 2026 | AWARD | 161,665 | — | — | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Feb 4, 2026 | AWARD | 260,000 | $7.27 | $1.9M | Form 4 |
| Otero Jose Manuel | Chief Operating Officer | Feb 4, 2026 | AWARD | 65,000 | — | — | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Feb 4, 2026 | AWARD | 226,665 | $7.27 | $1.6M | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Feb 4, 2026 | AWARD | 44,665 | — | — | Form 4 |
| Bhalla Narinder Pal | Jan 20, 2026 | OTHER | 0 | — | — | Form 4 | |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Nov 18, 2025 | SELL | 1,127 | $9.27 | $10.4K | Form 4 |
| Adler Eric | Chief Medical Officer | Nov 18, 2025 | SELL | 615 | $9.27 | $5.7K | Form 4 |
| See Tai Sandi | Chief Development Officer | Nov 18, 2025 | SELL | 386 | $9.27 | $3.6K | Form 4 |
| Robertson Jenny | Chief Legal Officer | Nov 18, 2025 | SELL | 549 | $9.27 | $5.1K | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Aug 18, 2025 | SELL | 721 | $9.27 | $6.7K | Form 4 |
| See Tai Sandi | Chief Development Officer | Oct 15, 2025 | AWARD | 10,890 | — | — | Form 4 |
| See Tai Sandi | Chief Development Officer | Oct 17, 2025 | SELL | 3,844 | $8.94 | $34.3K | Form 4 |
| See Tai Sandi | Chief Development Officer | Oct 17, 2025 | SELL | 44 | $9.56 | $420.68 | Form 4 |
| Robertson Jenny | Chief Legal Officer | Oct 15, 2025 | AWARD | 9,900 | — | — | Form 4 |
| Robertson Jenny | Chief Legal Officer | Oct 17, 2025 | SELL | 3,486 | $8.94 | $31.1K | Form 4 |
| Robertson Jenny | Chief Legal Officer | Oct 17, 2025 | SELL | 40 | $9.56 | $382.44 | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Oct 15, 2025 | AWARD | 5,940 | — | — | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Oct 17, 2025 | SELL | 2,091 | $8.94 | $18.7K | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Oct 17, 2025 | SELL | 24 | $9.56 | $229.46 | Form 4 |
| Adler Eric | Chief Medical Officer | Oct 15, 2025 | AWARD | 9,570 | — | — | Form 4 |
| Adler Eric | Chief Medical Officer | Oct 17, 2025 | SELL | 3,344 | $8.94 | $29.9K | Form 4 |
| Adler Eric | Chief Medical Officer | Oct 17, 2025 | SELL | 38 | $9.56 | $363.32 | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Oct 15, 2025 | AWARD | 33,000 | — | — | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Oct 17, 2025 | SELL | 12,985 | $8.94 | $116.0K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Oct 17, 2025 | SELL | 148 | $9.56 | $1.4K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Sep 12, 2025 | AWARD | 2,193 | $2.64 | $5.8K | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Aug 29, 2025 | AWARD | 280,000 | $4.79 | $1.3M | Form 4 |
| Tamayo Louis Edward | Chief Financial Officer | Aug 29, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Tamayo Louis Edward | Aug 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Otero Jose Manuel | Chief Technical Officer | Aug 18, 2025 | SELL | 2,848 | $4.67 | $13.3K | Form 4 |
| Robertson Jenny | Chief Legal Officer | Aug 18, 2025 | SELL | 542 | $4.67 | $2.5K | Form 4 |
| Adler Eric | Chief Medical Officer | Aug 18, 2025 | SELL | 608 | $4.67 | $2.8K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Aug 18, 2025 | SELL | 2,735 | $4.67 | $12.8K | Form 4 |
| See Tai Sandi | Chief Development Officer | Aug 18, 2025 | SELL | 382 | $4.67 | $1.8K | Form 4 |
| Tanguler Tolga | director | Jun 26, 2025 | AWARD | 14,583 | $4.18 | $61.0K | Form 4 |
| Van Hauwermeiren Timothy | director | Jun 26, 2025 | AWARD | 22,916 | $4.18 | $95.8K | Form 4 |
| DIAZ REINALDO M | director | Jun 26, 2025 | AWARD | 25,000 | $4.18 | $104.5K | Form 4 |
| COOPERSTONE BRENDA | director | Jun 26, 2025 | AWARD | 25,000 | $4.18 | $104.5K | Form 4 |
| CHOLMONDELEY PAULA H | director | Jun 26, 2025 | AWARD | 25,000 | $4.18 | $104.5K | Form 4 |
| Altschuler Steven | director | Jun 26, 2025 | AWARD | 25,000 | $4.18 | $104.5K | Form 4 |
| Agger Mette Kirstine | director | Jun 26, 2025 | AWARD | 25,000 | $4.18 | $104.5K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | May 16, 2025 | SELL | 1,074 | $2.77 | $3.0K | Form 4 |
| Adler Eric | Chief Medical Officer | May 16, 2025 | SELL | 585 | $2.77 | $1.6K | Form 4 |
| Robertson Jenny | Chief Legal Officer | May 16, 2025 | SELL | 521 | $2.77 | $1.4K | Form 4 |
| See Tai Sandi | Chief Development Officer | May 16, 2025 | SELL | 367 | $2.77 | $1.0K | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Mar 14, 2025 | AWARD | 5,720 | $2.61 | $14.9K | Form 4 |
| Robertson Jenny | Chief Legal Officer | Mar 14, 2025 | AWARD | 5,720 | $2.61 | $14.9K | Form 4 |
| See Tai Sandi | Chief Development Officer | Mar 14, 2025 | AWARD | 5,720 | $2.61 | $14.9K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Mar 14, 2025 | AWARD | 2,128 | $2.61 | $5.6K | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Feb 19, 2025 | SELL | 4,326 | $4.41 | $19.1K | Form 4 |
| See Tai Sandi | Chief Development Officer | Feb 19, 2025 | SELL | 1,486 | $4.41 | $6.6K | Form 4 |
| Adler Eric | Chief Medical Officer | Feb 19, 2025 | SELL | 2,359 | $4.41 | $10.4K | Form 4 |
| Robertson Jenny | Chief Legal Officer | Feb 19, 2025 | SELL | 2,101 | $4.41 | $9.3K | Form 4 |
| Rasbach Kyle | Chief Financial Officer | Jan 17, 2025 | AWARD | 245,250 | $5.07 | $1.2M | Form 4 |
| Rasbach Kyle | Chief Financial Officer | Jan 17, 2025 | AWARD | 40,875 | — | — | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Jan 7, 2025 | AWARD | 103,750 | — | — | Form 4 |
| Townsend Richard Nolan | director, officer: Chief Executive Officer | Jan 7, 2025 | AWARD | 207,500 | $7.33 | $1.5M | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Jan 7, 2025 | AWARD | 26,250 | — | — | Form 4 |
| Otero Jose Manuel | Chief Technical Officer | Jan 7, 2025 | AWARD | 52,500 | $7.33 | $384.8K | Form 4 |
| Robertson Jenny | Chief Legal & Admin Officer | Jan 7, 2025 | AWARD | 72,500 | $7.33 | $531.4K | Form 4 |
| Robertson Jenny | Chief Legal & Admin Officer | Jan 7, 2025 | AWARD | 36,250 | — | — | Form 4 |